Ran Li

12PUBLICATIONS
52CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 28, 2026
T cell-mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell-engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse models.

|Mar 03, 2025
Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes.

Ran Li, Abigail K Grosskopf, Louis R Joslyn

|Jan 03, 2024
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK.

Ran Li, Edward Dere, Mandy Kwong

|Jun 08, 2023
Thyroid Cancers Exhibit Oncogene-Enhanced Macropinocytosis that Is Restrained by IGF1R and Promote Albumin-Drug Conjugate Response.

Huiyu Hu, Thomas S C Ng, Mikyung Kang

|Apr 29, 2022
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.

Thomas S C Ng, Huiyu Hu, Stefan Kronister

|Oct 27, 2020
Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer.

Thomas S C Ng, Viswanath Gunda, Ran Li

Pageof 2

Frequent Collaborators

8 joint publications

Ralph Weissleder

7 joint publications

Rainer H Kohler

7 joint publications

Miles A Miller

4 joint publications

Thomas S C Ng